HISOCELL

High Throughput Multimodal Microfluidic Sorting and Biological Analysis of Circulating Tumour Cells

 Coordinatore INSTITUT CURIE 

 Organization address address: 26, rue d'Ulm
city: PARIS
postcode: 75248

contact info
Titolo: Ms.
Nome: Corinne
Cognome: Cumin
Email: send email
Telefono: +33 1 56 24 66 20
Fax: +33 1 56 24 66 27

 Nazionalità Coordinatore France [FR]
 Totale costo 194˙046 €
 EC contributo 194˙046 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2013-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-04-01   -   2016-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    INSTITUT CURIE

 Organization address address: 26, rue d'Ulm
city: PARIS
postcode: 75248

contact info
Titolo: Ms.
Nome: Corinne
Cognome: Cumin
Email: send email
Telefono: +33 1 56 24 66 20
Fax: +33 1 56 24 66 27

FR (PARIS) coordinator 194˙046.60

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

laquo    module    tumour    device    sorting    cells    microfluidic    treatments    treatment    protocols    clinicians    capture    ctc    pre    raquo   

 Obiettivo del progetto (Objective)

'There is today a huge interest in the clinical community regarding circulating tumour cells (CTC), as easy and minimally invasive « liquid biopsies ». They should provide, during the « blind » period following primary treatment of a cancer, a powerful tool to evaluate the risk of metastatic development, to follow in real time the efficiency of treatments, and guide clinicians in the prescription of alternative treatment. In the present project, I want to apply my expertise in microfluidics, microfabrication and analytical biochemistry to a major bottleneck hindering progress in this field :CTCs are present in the blood at typical levels of less than 1 per ml and current systems do not provide the performances required for an efficient CTC capture and a careful analysis. The group of Dr. Viovy have developed with support of ANR MICAD and EU project CAMINEMS a microfluidic CTC sorting system (EPHESIA) based on immune-affinity capture technology. I would like to expand the performance of this system in terms of sensitivity and integrate multi-modal analysis. Our objective is first to develop a new pre-treatment module integrating biological separation protocols that are currently done manually within an automated microfluidic device. In a second step a novel generation of cell sorting microfluidic device will allow the integration and directed assembly of complex and mobile microfabricated particles (metallic or magnetic).functionalized to selectively sort CTC based on multiple antibodies capture protocols. It will provide unique opportunities to manipulate or release individual CTC for further culture and analysis. Final aims of the proposed project are to connect both modules in a microfluidic system (sample pre-treatment module and multi-ligand capture module) and transfer this technology to clinicians to address the critical question of tumour cells subpopulations in particular for patients in a early stage in which treatments have most chances of success.'

Altri progetti dello stesso programma (FP7-PEOPLE)

TRANSFORM-EO (2013)

Towards the opeRAtioNal Surface Fluxes and sOil Moisture Retrievals from Earth Observation data

Read More  

STEM CELLS AND AGING (2013)

Stem cell niche and asymmetric division in aging

Read More  

WORHD (2008)

Written language processing in Hearing and Deaf

Read More